-
Leerink Swann Rates Medivation (MDVN) Market Perform
Tuesday, March 16, 2010 - 8:50amLeerink Swann analysts Howard Liang and Jonathan Eckard rated shares of Medivation, Inc. (Nasdaq: MDVN) a Market Perform with a valuation of $14. The analysts said that the negative readout for the Phase III CONNECTION trial for Dimebon, without any efficacy signal, leads them to believe that...
Read More >>
